Corporate world is helping employees deal with the global HIV/AIDS epidemic

NewsGuard 100/100 Score

Major companies are creating a wide variety of programs to help employees deal with the global HIV/AIDS epidemic, according to a report released by The Conference Board, the global business research and membership organization.

The report finds that 82 percent of the 134 major firms surveyed have HIV/AIDS programs aimed at helping employees already suffering from the disease or at risk of infection. The study is based on a survey of 134 leading health-benefits and HR executives, as well as in-depth interviews with directors of company HIV/AIDS programs and attorneys specializing in disability and HIV/AIDS law. The study builds on a 1997 report on the corporate response to this dilemma. It also draws on the experiences of companies whose operations in sub-Saharan Africa and other high-prevalence regions have put them on the disease's front lines.

More than two-thirds of the surveyed companies have been affected by HIV/AIDS, with one-fifth of these firms anticipating a growing impact of this epidemic over the next three years. Sub-Saharan Africa accounted for 67 percent of all adults and children suffering from HIV last year. The disease has yet to peak in most of southern Africa.

Asia, Latin America and Eastern Europe/Central Asia are high-risk regions. Asia accounted for 14.5 percent of global HIV cases in 2007, and a 23.1 percent rise in the rate of the newly infected between 2001 and 2007. Latin America accounted for 4.8 percent of all cases and a 23.1 percent increase in new infections. Eastern Europe/Central Asia accounted for 4.8 percent of all cases, and a 34 percent hike in new infections.

A Worldwide Dilemma
Worldwide, the number of people living with HIV rose from 29 million in 2001 to 33.2 million in 2007. Forty percent of new cases are among individuals 15 to 24, the age at which employees are just entering the workforce and will require ever greater medical care throughout their working lives. Companies feel the impact of HIV/AIDS in many ways. Fewer skilled workers and managers, greater absenteeism and turnover, and higher healthcare and insurance costs can reduce productivity and increase expenses.

“While there is no cure, medical advances have made it possible for people with the disease to live longer, achieve better quality of life, and be more productive, both at home and in the workplace,” said Henry Silvert, Research Associate at The Conference Board and author of the report. “In response to this new reality, and faced with an expected growth of new infections, more companies have been stepping up efforts to provide programs that effectively meet the needs of their employees living with the disease, or the risk of infection.”

In 1997, The Conference Board published its first report on the corporate response to HIV/AIDS. Ten years later, HIV/AIDS in the Workplace examines the current state of company programs around the world. The report examines trends, best practices, benefits and challenges that executives have faced in their efforts to tackle the HIV/AIDS needs of their employees.
Some key findings:

  • Few firms have totally escaped the impact of HIV/AIDS. Over two-thirds of respondents' company operations have been affected by HIV/AIDS. One-fifth expect more impact from HIV/AIDS over the next three years.
  • More than 90 percent of firms plan to maintain or increase their spending on HIV/AIDS over the coming years. Firms with operations in high-prevalence sub-Saharan Africa lead in planned spending increases.
  • North America and Western/Central Europe account for 3.9 percent and 2.3 percent of all HIV cases, respectively, and experienced flat rates of new infections between 2001 and 2007.
  • Regardless of location, respondents identified the following non-financial concerns as the top motivators for investing in HIV/AIDS related programs: social responsibility; creating and sustaining an inclusive environment for all employees; welfare of employees living with HIV/AIDS.
  • Three-quarters of firms report some type of gain from their programs. Top gains include increased awareness of the risk factors associated with HIV/AIDS, decreased fears of becoming infected, increased worker morale, increased motivation and commitment, and decreased absenteeism.
  • Corporate initiatives vary from education and prevention to counseling and treatment, depending on company priorities, industry and location. Companies in sub-Saharan Africa are most likely to offer on-site treatment.
  • Employee assistance programs were the top overall initiative in both the 1997 and 2007 surveys. Among companies with HIV/AIDS programs, education and training programs, resource and referral services, and HIV/AIDS counseling were the top initiatives.
  • Common hurdles include a lack of funds or personnel, an obstructive corporate culture that fosters resistance, and difficulty guaranteeing privacy and freedom from discrimination.
  • Support from top management is vital in encouraging buy-in from across the organization, along with disciplined follow-through and accountability.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New report on HIV drug resistance: Challenges and recommendations